
<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/joey/Project/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.4.2-SNAPSHOT" ident="GROBID" when="2017-08-10T23:47+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Gene expression Inference of combinatorial Boolean rules of synergistic gene sets from cancer microarray datasets</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2010">2010</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName>
								<forename type="first">Inho</forename>
								<surname>Park</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Bio and Brain Engineering</orgName>
								<orgName type="institution">KAIST</orgName>
								<address>
									<addrLine>373-1 Guseong-dong, Yuseong-gu</addrLine>
									<postCode>305-701</postCode>
									<settlement>Daejeon</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Kwang</forename>
								<forename type="middle">H</forename>
								<surname>Lee</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Bio and Brain Engineering</orgName>
								<orgName type="institution">KAIST</orgName>
								<address>
									<addrLine>373-1 Guseong-dong, Yuseong-gu</addrLine>
									<postCode>305-701</postCode>
									<settlement>Daejeon</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName>
								<forename type="first">Doheon</forename>
								<surname>Lee</surname>
							</persName>
							<email>dhlee@biosoft.kaist.ac.kr</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Bio and Brain Engineering</orgName>
								<orgName type="institution">KAIST</orgName>
								<address>
									<addrLine>373-1 Guseong-dong, Yuseong-gu</addrLine>
									<postCode>305-701</postCode>
									<settlement>Daejeon</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Gene expression Inference of combinatorial Boolean rules of synergistic gene sets from cancer microarray datasets</title>
					</analytic>
					<monogr>
						<title level="j" type="main">BIOINFORMATICS ORIGINAL PAPER</title>
						<imprint>
							<biblScope unit="volume">26</biblScope>
							<biblScope unit="issue">12</biblScope>
							<biblScope unit="page" from="1506" to="1512"/>
							<date type="published" when="2010">2010</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/bioinformatics/btq207</idno>
					<note type="submission">Advance Access publication April 21, 2010 Received on December 14, 2009; revised on March 19, 2010; accepted on April 16, 2010</note>
					<note>[09:41 21/5/2010 Bioinformatics-btq207.tex] Page: 1506 1506–1512 Republic of Korea Associate Editor: Joaquin Dopazo Supplementary information: Supplementary data are available at Bioinformatics online.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
				<p>Motivation: Gene set analysis has become an important tool for the functional interpretation of high-throughput gene expression datasets. Moreover, pattern analyses based on inferred gene set activities of individual samples have shown the ability to identify more robust disease signatures than individual gene-based pattern analyses. Although a number of approaches have been proposed for gene set-based pattern analysis, the combinatorial influence of deregulated gene sets on disease phenotype classification has not been studied sufficiently. Results: We propose a new approach for inferring combinatorial Boolean rules of gene sets for a better understanding of cancer transcriptome and cancer classification. To reduce the search space of the possible Boolean rules, we identify small groups of gene sets that synergistically contribute to the classification of samples into their corresponding phenotypic groups (such as normal and cancer). We then measure the significance of the candidate Boolean rules derived from each group of gene sets; the level of significance is based on the class entropy of the samples selected in accordance with the rules. By applying the present approach to publicly available prostate cancer datasets, we identified 72 significant Boolean rules. Finally, we discuss several identified Boolean rules, such as the rule of glutathione metabolism (down) and prostaglandin synthesis regulation (down), which are consistent with known prostate cancer biology. Availability: Scripts written in Python and R are available at http://biosoft.kaist.ac.kr/∼ihpark/. The refined gene sets and the full list of the identified Boolean rules are provided in the Supplementary</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">INTRODUCTION</head><p>With the advent of microarray technologies, genome-wide gene expression profiling has become a crucial tool in biomedical research during the past few decades. In cancer research, genome-wide gene expression profiling has been used to discover new cancer subtypes (<ref type="bibr" target="#b22">Golub et al., 1999;</ref><ref type="bibr" target="#b32">Lapointe et al., 2004;</ref><ref type="bibr" target="#b56">Sorlie et al., 2003</ref>); to develop gene expression signatures for cancer diagnosis, prognosis or prediction of drug responsiveness (<ref type="bibr" target="#b43">Nevins and Potti, 2007</ref>; Potti * To whom correspondence should be addressed<ref type="bibr">van't Veer et al., 2002</ref>); and to identify cancer associated signaling pathways or cellular processes (<ref type="bibr" target="#b5">Bild et al., 2006;</ref><ref type="bibr" target="#b24">Heiser et al., 2009</ref>). In a typical analysis of cancer gene expression profiles, individual genes are ranked by the statistical significance of the differential expression between two different experimental conditions; several tens of top-ranked genes are then selected for further analysis, such as cancer classification (<ref type="bibr" target="#b22">Golub et al., 1999;</ref><ref type="bibr" target="#b32">Lapointe et al., 2004;</ref><ref type="bibr" target="#b43">Nevins and Potti, 2007;</ref><ref type="bibr" target="#b51">Potti et al., 2006;</ref><ref type="bibr" target="#b56">Sorlie et al., 2003;</ref><ref type="bibr">van't Veer et al., 2002</ref>) and functional enrichment analysis (<ref type="bibr">AlShahrour et al., 2007;</ref><ref type="bibr" target="#b13">Dennis et al., 2003;</ref><ref type="bibr" target="#b26">Huang et al., 2009</ref>). To investigate the combinatorial influences of deregulated genes on disease phenotype classification, researchers have proposed a number of multivariate approaches (<ref type="bibr" target="#b6">Bo and Jonassen, 2002;</ref><ref type="bibr" target="#b41">Mukherjee et al., 2009;</ref><ref type="bibr" target="#b62">Varadan and Anastassiou, 2006</ref>). However, all of these individual gene-based approaches tend to produce unstable gene lists or combinations of genes due to the small sample size used in individual studies (<ref type="bibr" target="#b1">Ambroise et al., 2002;</ref><ref type="bibr" target="#b10">Chuang et al., 2007</ref>). A recently developed type of gene set analysis aims to directly evaluate the statistical significance of coordinated expression changes of genes belonging to specific pathways or functional categories without selecting an arbitrary number of highly ranked genes in advance, and the gene sets are usually derived from the Gene Ontology (<ref type="bibr" target="#b3">Ashburner et al., 2000</ref>), Kyoto Encyclopedia of Genes and Genomes (KEGG;<ref type="bibr" target="#b30">Kanehisa et al., 2004</ref>), Reactome (<ref type="bibr" target="#b63">Vastrik et al., 2007</ref>), and other knowledge bases. These approaches have the ability to detect gene sets whose constituent genes show 'subtle but coordinated expression changes,' which might not be detected by conventional functional enrichment methods (<ref type="bibr" target="#b14">Dinu et al., 2009;</ref><ref type="bibr" target="#b39">Mootha et al., 2003;</ref><ref type="bibr" target="#b42">Nam and Kim, 2008;</ref><ref type="bibr" target="#b57">Subramanian et al., 2005;</ref><ref type="bibr" target="#b58">Tian et al., 2005</ref>). Moreover, several cancer classification approaches based on the gene set activities inferred from individual samples perform better than other cancer classification approaches based on the expression levels of individual genes (<ref type="bibr" target="#b16">Edelman et al., 2006;</ref><ref type="bibr">Lee et al., 2008a;</ref><ref type="bibr" target="#b35">Levine et al., 2006;</ref><ref type="bibr" target="#b46">Pang et al., 2006</ref>). Besides the gene set based cancer classification approaches, various other approaches to the study of interdependencies among gene modules have been proposed.<ref type="bibr" target="#b52">Segal et al. (2004</ref><ref type="bibr" target="#b53">Segal et al. ( , 2003</ref>) proposed a module network for learning about transcriptionally coexpressed modules and their dependency structure so that gene expression patterns in different types of cancer could be characterized. That model differs from other gene set dependency models in that it learns about the gene modules and their dependency structure simultaneously from data rather than fromPage: 1507 1506–1512</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inferring Boolean rules of gene sets</head><p>predefined gene sets.<ref type="bibr" target="#b59">Tomlins et al. (2006)</ref>defined more than 14 000 molecular concepts as gene sets of functionally related genes or differentially expressed genes detected from cancer gene expression datasets; they also constructed a molecular concept map that connects two molecular concepts provided the number of overlapping genes between them is statistically significant. Along with the advantage of the unprecedented large collection of gene sets, the approach of<ref type="bibr" target="#b59">Tomlins et al. (2006)</ref>can relate a list of the differentially expressed genes of an experiment to other previously conducted experiments and to the curated concepts.<ref type="bibr" target="#b59">Tomlins et al. (2006)</ref>used the molecular concept map to analyze prostate cancer expression profiles, and they could detect enriched subnetworks related to prostate cancer progression models (<ref type="bibr" target="#b59">Tomlins et al., 2006</ref>). However, with their approach there is still a need to select a number of differentially expressed genes between the two experimental conditions, so that enriched subnetworks can be detected; and that requirement makes it difficult to deal with heterogeneous patterns of gene set activities among cancer samples.<ref type="bibr">Pang et al.</ref>proposed the use of a random forest algorithm for pathway clustering. They use the genes in each pathway to build a random forest classifier and then use the class votes of each classifier to construct feature vectors of each pathway. The feature vectors are then applied to a tight clustering algorithm for identification of the pathway clusters (<ref type="bibr" target="#b47">Pang et al., 2008</ref>). Inferring gene set dependency models based on gene set activities inferred for each sample has been proposed recently.<ref type="bibr">Edelman et al.</ref>proposed a method of detecting pathway dependencies in prostate cancer progression models with 639 canonical pathways available at the Molecular Signature Database (MSigDB). In their approach, they used ASSESS to measure enrichment scores of pathways in individual samples (<ref type="bibr" target="#b16">Edelman et al., 2006</ref>). They also used the covariance structure of the enrichment scores to infer a pathway dependency structure relevant to the progression models (<ref type="bibr" target="#b17">Edelman et al., 2008</ref>). Although their approach was successful in identifying pathways relevant to the cancer progression models, they have not explicitly used the pathway dependency models to construct predictive models. In this work, we propose a new approach to the task of inferring combinatorial Boolean rules of gene sets for a better understanding of cancer gene expression profiles as well as cancer classification. To this end, we first identify coherently expressed submodules of each gene set belonging to the 639 canonical pathways available at the MSigDB (<ref type="bibr" target="#b57">Subramanian et al., 2005</ref>) and use the submodules as background gene sets for further analysis. Second, we infer gene set activities in individual samples by using gene expression profiles and then binarize them. Third, we construct a gene set synergy network (<ref type="bibr" target="#b64">Watkinson et al., 2008</ref>); we use that network to search for small groups of synergistic gene sets that provide rich information on the disease status of samples. Finally, we extract significant Boolean rules of the gene sets within each identified group and validate the rules by using independent test datasets. For comparison with other approaches, we use a random forest classifier for classification analysis of the identified Boolean rules (<ref type="bibr" target="#b8">Breiman, 2001</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Datasets and preprocessing</head><p>We analyzed publicly available prostate cancer gene expression datasets with our proposed approach. The datasets of<ref type="bibr" target="#b32">Lapointe et al. (2004</ref>) and<ref type="figure" target="#tab_1">Table 1</ref>summarizes the properties of the datasets. Where &lt;20% of the values of the probe set in a dataset were missing, we used the LLSimpute method (<ref type="bibr" target="#b31">Kim et al., 2005</ref>) to impute the missing values. Whenever a higher portion of values was missing, we excluded the probe set from the subsequent analysis. We performed quantile normalization among the arrays (<ref type="bibr" target="#b7">Bolstad et al., 2003</ref>), and we finally normalized the expression profile of each probe set to approximate a standard normal distribution across the samples. The expression profiles of the probe sets for each gene were summarized with the mean of their expression values.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Refinement of gene sets</head><p>As for gene sets, we downloaded the 639 canonical pathways from the MSigDB (<ref type="bibr" target="#b57">Subramanian et al., 2005</ref>). Because the inclusion of genes that are not coherent with the other genes in a gene set can hinder the performance of our analysis, we redefined the 639 canonical pathways by identifying tightly coregulated submodules in the training datasets. The coherence of the expression values of a gene set can be measured in a number of ways. One most widely used measurement approaches is to use the fraction of significantly correlated pairs of genes out of all the possible pairs of genes in a gene set (<ref type="bibr" target="#b50">Pilpel et al., 2001</ref>). To identify tightly coregulated submodules for each gene set, we first calculated the pairwise rank correlation coefficients of all the pairs of genes in the gene set. We then constructed a correlation gene network that connects genes that have a significant positive rank correlation coefficient (P &lt; 0.05) and applied a hierarchal graph clustering method called the fitHRG algorithm (<ref type="bibr" target="#b12">Clauset et al., 2008</ref>) to the gene correlation network so that we could identify densely connected subnetworks. For each gene set, we selected maximal subnetworks with a connection ratio &gt;0.8. Subnetworks composed of less than three genes were excluded from further analysis. As a result, we obtained 809 gene sets from the analysis of the gene correlation networks derived from the 639 canonical pathways. The redefined gene sets are provided in the Supplementary Materials.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Inference of gene set activity</head><p>After assuming that genes in a refined gene set are coherent, we used the normalized mean of expression values as the activity of a gene set in an individual sample. Let z kj be a normalized expression value of a gene, g k , in a sample, j , and let P i be a set of genes. The activity of gene set P i in a sample, j, can then be measured with the following equation (<ref type="bibr" target="#b27">Jiang and Gentleman, 2007;</ref><ref type="bibr" target="#b58">Tian et al., 2005</ref>):</p><formula>a ij = g k ∈P i z kj √ |P i | .</formula><formula>(1)</formula><p>We binarized the activity values of each gene set by using a median binarization method for mining Boolean rules of gene sets. Page: 1508 1506–1512<ref type="bibr" target="#b4">Batagelj and Mrvar, 2002</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>I.Park et al.</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">Gene set synergy network</head><p>To search for interdependency structures among the refined 809 gene sets, we used the recently developed information theoretic measure of synergy to measure the level of cooperativity between all the pair of gene sets. The synergy between two predictive random variables, X and Y , with respect to a dependent random variable, C, which denotes the disease status of a sample in our framework, is defined as follows (<ref type="bibr" target="#b2">Anastassiou, 2007;</ref><ref type="bibr" target="#b23">Hanczar et al., 2007;</ref><ref type="bibr" target="#b64">Watkinson et al., 2008</ref>):</p><formula>Syn(X,Y ;C) = I(X,Y ;C)−[I(X;C)+I(Y ;C],</formula><formula>(2)</formula><p>where the I(X;C) is used to denote the mutual information between the two random variables X and C. Thus, the synergy, Syn(X,Y ;C) , can be interpreted as the amount of additional information about C when the two predictive variables X and Y are considered simultaneously rather than individually. To assess the statistical significance of synergy, we use a permutation test that randomly shuffles gene set activities within each class of disease phenotype. As a result, we identified 421 pairs of gene sets that have significant synergy (P &lt; 0.05) as well as significant mutual information with the sample phenotypes (P &lt; 0.05) from the training datasets.<ref type="figure" target="#fig_1">Figure 1</ref>shows the synergy network constructed with the pairs of synergistic gene sets. The synergy network shows that prostate cancer related gene sets, namely the glutathione metabolism and O-glycan biosynthesis gene sets, have many synergistic partner gene sets for prostate cancer classification.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">Synergistic hierarchical clustering</head><p>We searched synergistic clusters of gene sets that have rich information about the sample phenotypes within the synergy network. For this purpose, we constructed dendrograms with the following procedure:</p><p>(1) Each gene set is considered an isolated gene set cluster.</p><p>(2) The pairwise synergies among the gene set clusters are computed with the Equation (3).</p><p>(3) Two clusters that have highest synergy are merged.</p><p>(</p><formula>where PS i ={P i1 ,··· ,P in } and PS j ={P j1 ,··· ,P jm }</formula><p>are sets of gene sets and I(PS i ;C) is an abbreviation of I(P i1 ,··· ,P in ;C). We introduce the parameter α to adjust a bias of synergy towards a negative value when I(PS i ;C) and I(PS j ;C) are large (as shown in the Supplementary<ref type="figure" target="#fig_1">Fig. S1</ref>). A larger α tends to greedily merge two gene set clusters to maximize joint mutual information between sample phenotypes and gene sets in a merged cluster, whereas a smaller α tends to merge two gene set clusters that have a large synergy value between the clusters. We use α = 1,2,··· ,5 to produce gene set dendrograms and select subclusters of gene set dendrograms if the conditional entropy of sample phenotypes is &lt;0.4. (See<ref type="figure" target="#fig_2">Fig. 2</ref></p><formula>D i and D j in the graph G //Merge(D i ,D j ) returns a dendrogram D m = (D i ,D j ,the union of elements in D i and D j )</formula><p>Algorithm 1: Construction of gene set synergy dendrograms</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6">Entropy estimation</head><p>For a small sample size, the maximum likelihood estimator, ˆ H MLE , tends to underestimate the entropy of observations. When the conditional entropy of sample phenotypes is calculated, the number of samples that fall in each Boolean state of the gene set activities decreases as the number of predictive gene sets increases. To avoid underestimation of the maximum likelihood entropy estimator for such a small sample size, we use the Miller–Madow estimator, ˆ H MM , which is expressed as follows (<ref type="bibr" target="#b48">Paninski et al., 2003</ref>):The term H(C|R i ) denotes the class entropy of samples selected by rule R i. The selected rules (*) are investigated to find known or putative synergistic relations among the gene sets.<ref type="figure" target="#tab_3">Table 3</ref>shows the gene sets that appear in the rules. With Equation (4), the bias of the maximum likelihood estimator, ˆ H MLE , can be corrected by adding the estimated bias term m−1 2N , where is the number of possible observations (that is, normal and cancer) and m is the number of samples within each Boolean condition of the gene set activities. We use n i andˆpandˆ andˆp i to denote the number of samples and estimated probability in each phenotypic state under a Boolean condition of gene set activities.</p><formula>ˆ p i = n i N , ˆ H MLE = m i=1ˆp i=1ˆ i=1ˆp i logˆplogˆp i , ˆ H MM = ˆ H MLE + m−1 2N .</formula><formula>(4)</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">RESULTS AND DISCUSSION</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Boolean rules of synergistic gene sets</head><p>Synergistic hierarchical clustering methods identified 31 groups of synergistic gene sets with a low threshold of conditional entropy; i.e.</p><formula>H(C|P i1 ,··· ,P ik ) &lt; 0.4</formula><p>. From each identified small group of gene sets, we were able to extract significant Boolean rules by evaluating the significance of all the possible conjunctive Boolean functions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">Validation with independent datasets</head><p>We validated the identified Boolean rules by using the datasets of<ref type="bibr" target="#b59">Tomlins et al. (2006) and</ref><ref type="bibr" target="#b65">Yu et al. (2004)</ref>. To quantify the level of agreement between the Boolean rules and the gene expression profiles of each test dataset, we devised a following scheme from the log-rank sum approach (<ref type="bibr" target="#b9">Breitling et al., 2004</ref>). With the Boolean rule</p><formula>R = (P p1 ∧···∧P pk )∧(¬P n1 ∧···∧¬P nm ), we divided the literals into PL ={P p1 ,...,P pk } and NL = {P n1 ,...,P nm }</formula><p>to, respectively, represent the sets of gene sets that positively and negatively participate in the rule. We then constructed rank profiles for each element of PL and NL in ascending and descending order, respectively. Finally, we calculated the sum of the log-ranks from the rank profiles of the literals for each sample. To test the significance of each rule, we performed a rank-sum test for the sum of the log-ranks of the literals of the normal and cancer samples.<ref type="figure" target="#tab_2">Table 2</ref>shows top 20 Boolean rules validated from the test datasets;<ref type="figure" target="#tab_3">Table 3</ref>shows the gene sets that appear in the selected rules. Several selected rules are discussed below.<ref type="figure" target="#fig_3">Figure 3</ref>shows scatter plots of samples; these plots are based on the activities of the gene sets included in the most significant rules, R 1 and R 2. @BULLET R 1 : glutathione metabolism (down) and prostaglandin synthesis regulation (down) The glutathione s-transferases (GSTs) are known to be involved in the metabolism of carcinogens and in the defense against reactive oxygen species.<ref type="bibr" target="#b40">Moskaluk et al. (1997)</ref>confirmed the down-regulation of π-class GSTs in adenocarcinoma of the prostate. In many types of cancer, COX-2 is known to be overexpressed, and the overexpression of COX-2 leads overproduction of prostaglandin E2 (<ref type="bibr" target="#b21">Eruslanov et al., 2009</ref>). Note also that the highly selective inhibitor of COX-2, celecoxib, has been researched for use in cancer treatments as a supplement topain treatments. Our analysis shows no significant change in the COX-2 expression level for the prostate cancer samples, though the other member genes PTGER2, PTGIS, EDNRA, and EDNRB are significantly down-regulated. (<ref type="bibr" target="#b29">Jakobsson et al., 1999</ref>) identified a glutathione-dependent prostaglandin E synthase, which might be a cause of the down-regulation of prostaglandin synthesis regulation in the primary prostate cancer. Recently, GSTP1 and PTGDS have been proposed as key molecules in prostate cancer classification (<ref type="bibr" target="#b62">Varadan and Anastassiou, 2006;</ref><ref type="bibr" target="#b64">Watkinson et al., 2008</ref>). @BULLET R 2 : insulin-dependent diabetes mellitus (up) and transforming growth factor (TGF )-β-dependent SMAD signaling (down) The association of prostate cancer risk and insulin-dependent diabetes has been reported in several population-based studies (<ref type="bibr" target="#b25">Hsing et al., 2001;</ref><ref type="bibr" target="#b49">Pierce et al., 2008</ref>). In our analysis, the submodule of insulin-dependent diabetes mellitus that contains ICA1, PTPRN2, and CPE shows a higher level of activation in primary prostate cancer. On the other hand, an androgen receptor (AR) has been known to negatively modulate TGF-β-dependent SMAD signalling in AR-dependent prostate cancer (van der<ref type="bibr" target="#b60">Poel et al., 2005</ref>); thus TGF-β-dependent SMAD signalling is down-regulated in AR-dependent prostate cancer. Interestingly,<ref type="bibr" target="#b36">Lin et al. (2009)</ref>reported that the TGF-β signalling effector SMAD3 represses insulin gene transcription in pancreatic islet cells. @BULLET R 6 : purine metabolism (up) and nicotine and nicotinate metabolism (down) Alteration of the purine metabolism either facilitates production or retards degradation of adenosine, which is the main element of ATP (<ref type="bibr" target="#b37">Linden et al., 2006</ref>).<ref type="bibr" target="#b44">Obajimi et al. (2009)</ref>showed that inhibition of de novo purine synthesis in LNCaP cells results in ATP depletion. On the other hand, the nicotin and nicotinate metabolism, which includes AOX1 and NTE5, is related to antioxidation of reactive oxygen species (<ref type="bibr" target="#b15">Dong et al., 2008</ref>(<ref type="bibr" target="#b38">Litvinov et al., 2006</ref>); in addition, the DNA replication regulation protein MCM7 has been suggested for use as a proliferation marker in prostate cancer (<ref type="bibr" target="#b45">Padmanabhan et al., 2004</ref>). On the other hand, the G1 pathway is an important checkpoint of cell proliferation. Thus, the tumor cells undergo uncontrolled proliferation by destroying the G1 pathway while activating the DNA replication pathway. @BULLET R 18 : complement and coagulation (down), calmodulin (down) and TERT pathway (up) The genes SERPINA5 and SERPING1, which are involved in the complement and coagulation pathway, are important for preventing cancer cell growth and metastasis in breast and prostate cancer (<ref type="bibr" target="#b54">Sieben et al., 2005</ref>). Calmodulin is known as a negative modulator of ARs, which play an important role in AR breakage (<ref type="bibr" target="#b11">Cifuentes et al., 2004</ref>). Therefore, the loss of expression of those genes promotes the development of prostate cancer. In the TERT pathway, the genes HDAC1, MYC, MZF1 and SP3 show higher expression levels in prostate cancer; they contribute to the survival and proliferation of cancer cells (<ref type="bibr">Lee et al., 2008b</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inferring Boolean rules of gene sets</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Classification analysis</head><p>We used the discovered Boolean rules of the gene sets to perform classification analysis. We obtained feature vectors in individual samples for the Boolean rules with the log-rank sum of literals in the rule described in the previous section, and we constructed random forest classifiers (<ref type="bibr" target="#b8">Breiman, 2001</ref>) for the test datasets by using the features selected from the training datasets. Using the cross-validation errors and the area under the curve (as shown in<ref type="figure" target="#fig_4">Fig. 4</ref>), we compared the overall classification performances with the classification based on the genes and gene sets. For independent datasets, our results are comparable the classification based on genes and gene sets.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">CONCLUSION</head><p>We have presented a method of inferring Boolean rules of gene sets from cancer microarray datasets. We first identified small subsets of gene sets that are synergistic; we then enumerated all the possible conjunctive Boolean functions of the gene sets within each group of gene sets; and, finally, we evaluated the predictive powers of the Boolean functions. Although several approaches have been proposed to reveal the Boolean logic of individual molecules (<ref type="bibr" target="#b28">Ruczinski et al., 2003;</ref><ref type="bibr" target="#b41">Mukherjee et al., 2009;</ref><ref type="bibr" target="#b62">Varadan and Anastassiou, 2006</ref>), our method is different with those methods in that we try to identify relevant variables by using a synergy network before we search for the Boolean rules. We have identified and discussed several significant Boolean rules of gene sets that are frequently observed in prostate cancer. Our results show the possibility of using Boolean rules of gene sets for cancer classification, and the identified Boolean rules provide insights into the combinatorial influences of deregulated gene sets on cancer developments. The coverage of gene set analysis increases as the information on pathway interactions is accumulated. Thus, further research directions should include the pathway interaction information for the dissection of coherent submodules in a gene set.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><figDesc>[09:41 21/5/2010 Bioinformatics-btq207.tex]</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig.1.</head><figDesc>Fig. 1. A gene set synergy network extracted from the training datasets. In a simplification of the network, this figure shows only pairs of gene sets that have high mutual information with sample phenotypes (P &lt; 0.01) among the synergistic gene set pairs (P &lt; 0.05). The network is visualized with the Pajek software (Batagelj and Mrvar, 2002).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig.2.</head><figDesc>Fig. 2. A random distribution of the entropy of the sample phenotypes conditioned on a group of gene sets. We randomly sample 10 000 groups of gene sets for groups of each size.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig.3.</head><figDesc>Fig. 3. The scatter plots of samples using activities of gene sets in the Boolean rules R 1 (a and c) and R 2 (b and d).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig.4.</head><figDesc>Fig. 4. Comparison of classification performance: a tenfold cross-validation. The figure shows (a) cross-validation errors and (b) the area under t he curve of random forest classifiers, which are based on Boolean rules for genes, gene sets, and the sum of log-rank. The most significant 50 features are selected from the training datasets of each classifier.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><figDesc>Funding: Samsung Biomedical Research Institute (grant C-A7101-2); Korean National Research Laboratory (grant 2005-01450 to D.L.) of the Ministry of Science and Technology; Information Technology Research Center (grant IITA-2008-C1090-0801-0001 to D.L.).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head></head><figDesc>Conflict of Interest: none declared.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="true"><figDesc>Table 1. Prostate cancer microarray datasets</figDesc><table>Dataset 
Platform 
n n 
n t 

Traing set 
Singh et al. (2002) 
HG-U95A 
52 
50 
Lapointe et al. (2004) 
Spotted cDNA 
41 
62 
Test set 
Yu et al. (2004) 
HG-U95A 
18 
65 
Tomlins et al. (2006) 
Spotted cDNA 
27 
32 

The parameters n n and n t are the number of normal samples and cancer samples in a 
dataset. 

Singh et al. (2002) were used for learning the Boolean rules of gene sets, 
and the datasets of Tomlins et al. (2006) and Yu et al. (2004) were used for 
testing the learned Boolean rules. </table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" validated="false"><figDesc>4) Steps 2 and 3 are repeated until only k clusters remain. Equation (3) is expressed as follows: Syn α (PS i ,PS j ;C) = I(PS i ∪PS j ;C) α −[I(PS i ;C) α +I(PS j ;C) α ]. (3)</figDesc><table></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2" validated="false"><figDesc>for the random distribution of conditional entropy.) We might consider each gene set clusters produced with this approach as co-regulated functional modules in a specific = (a ij ) is a binarized gene set activity profiles; C = (c j ) denotes the disease status of a sample j. Input: G = (V ;E) is a gene set synergy network described with a set of vertices (gene sets), V , and edges, E, and α is a control parameter of merge process Output: Gene set synergy dendrograms Dendrograms = {D i = (null,null,{P i })|P i ∈ V } ; //A dendrogram is defined as (left child, right child, a set of elements) =∅; // contains synergy values of pairs of gene set clusters foreach pair of (D i ,D j ) in Dendrograms do synergy = syn α (ElementsOf(D i ),ElementsOf(D j );C) ; add (D i ,D j ,synergy) to ; end while |Dendrograms|==k do //k is the number of connected components in the graph G D ml ,D mr = argmax D i ,D j SynergyOf(D i ,D j ;) ; \{(D i ,D j ,synergy)|{D ml ,D mr }∩{D i ,D j } =∅} ; D merged = Merge(D ml ,D mr ) ; Dendrograms\{D ml ,D mr } foreach D k in Dendrograms do if Connected(D merged , D k ; G) then PS k = ElementsOf(D k ) ; PS merged = ElementsOf(D merged ) ; synergy = syn α (PS k ,PS merged ;C) ; add (D k ,D merged ,synergy) to ; end end add D merged to Dendrograms end //Each element in V corresponds to a random variable that represent row vectors of A = (a ij ) //ElementsOf(D i ) returns a set of elements included in D i //Connected(D i ,D j ;G) is TRUE if there is a path between a set of nodes in</figDesc><table>[09:41 21/5/2010 Bioinformatics-btq207.tex] 

Page: 1509 1506–1512 

Inferring Boolean rules of gene sets 

phenotype condition but not in all the conditions. The detailed procedure for 
constructing gene set synergy dendrograms using a hierarchical clustering 
algorithm is described in the Algorithm 1. 

Data: A </table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3" validated="false"><figDesc>Table 2.</figDesc><table>Significanct Boolean rules 

ID 
Rule 
Training 
Testing 
(rank-sum test) 
H(C|R i ) 
p tomlins 
p yu 

*R 1 
¬P 170 ¬P 640 
0.0078 
0.0002 
&lt;0.0001 

*R 2 
¬P 352 P 457 
0.0093 
0.0002 
0.0002 
R 3 
¬P 311 P 457 
0.0094 
0.0001 
&lt;0.0001 

R 4 
P 457 ¬P 476 
0.0098 
0.0025 
0.0008 
R 5 
P 224 ¬P 352 
0.0100 
0.0003 
0.0001 
*R 6 
P 224 ¬P 588 
0.0100 
0.0003 
0.0001 
R 7 
¬P 311 P 673 
0.0100 
&lt;0.0001 
&lt;0.0001 

R 8 
¬P 352 P 579 
0.0106 
&lt;0.0001 
0.0002 
*R 9 
P 114 ¬P 154 
0.0109 
0.0004 
0.0005 
R 10 
P 114 ¬P 476 
0.0109 
0.0071 
0.0002 
R 11 
P 224 ¬P 311 
0.0111 
0.0002 
&lt;0.0001 

R 12 
¬P 311 P 321 
0.0111 
0.0001 
&lt;0.0001 

R 13 
¬P 476 P 579 
0.0111 
&lt;0.0001 
&lt;0.0001 

R 14 
¬P 132 P 323 ¬P 784 
0.0119 
&lt;0.0001 
&lt;0.0001 

R 15 
¬P 311 P 692 
0.0119 
0.0002 
0.0002 
R 16 
¬P 352 P 457 ¬P 476 
0.0125 
0.0003 
&lt;0.0001 

R 17 
¬P 170 P 505 
0.0128 
0.0003 
0.0006 
*R 18 
¬P 405 ¬P 431 P 775 
0.0128 
0.0025 
&lt;0.0001 

R 19 
P 132 ¬P 323 P 784 
0.0128 
&lt;0.0001 
&lt;0.0001 

R 20 
P 342 ¬P 436 
0.0132 
&lt;0.0001 
&lt;0.0001 

</table></figure>

			<note place="foot">at :: on August 31, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct   xml:id="b0">
	<analytic>
		<title level="a" type="main">FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments</title>
		<author>
			<persName>
				<forename type="first">F</forename>
				<surname>Al-Shahrour</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="91" to="96" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b1">
	<analytic>
		<title level="a" type="main">Selection bias in gene extraction on the basis of microarray gene-expression data</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<surname>Ambroise</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">G</forename>
				<forename type="middle">J</forename>
				<surname>Mclachlan</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. Sci. USA</title>
		<meeting>. Natl Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="2002" />
			<biblScope unit="page" from="6562" to="6566" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b2">
	<analytic>
		<title level="a" type="main">Computational analysis of the synergy among multiple interacting genes</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Anastassiou</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Syst. Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">83</biblScope>
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b3">
	<analytic>
		<title level="a" type="main">Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Ashburner</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="25" to="29" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b4">
	<analytic>
		<title level="a" type="main">Pajek-analysis and visualization of large networks</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Batagelj</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Mrvar</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Graph Drawing</title>
		<imprint>
			<biblScope unit="volume">2265</biblScope>
			<biblScope unit="page" from="477" to="478" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b5">
	<analytic>
		<title level="a" type="main">Oncogenic pathway signatures in human cancers as a guide to targeted therapies</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">H</forename>
				<surname>Bild</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">439</biblScope>
			<biblScope unit="page" from="353" to="357" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b6">
	<analytic>
		<title level="a" type="main">New feature subset selection procedures for classification of expression profiles</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<surname>Bo</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Jonassen</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">17</biblScope>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b7">
	<analytic>
		<title level="a" type="main">A comparison of normalization methods for high density oligonucleotide array data based on variance and bias</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">M</forename>
				<surname>Bolstad</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="185" to="193" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b8">
	<analytic>
		<title level="a" type="main">Random forests</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Breiman</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mach. Learn</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="5" to="32" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b9">
	<analytic>
		<title level="a" type="main">Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments</title>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Breitling</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">573</biblScope>
			<biblScope unit="page" from="83" to="92" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b10">
	<analytic>
		<title level="a" type="main">Network-based classification of breast cancer metastasis</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<forename type="middle">Y</forename>
				<surname>Chuang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Syst. Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">140</biblScope>
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b11">
	<analytic>
		<title level="a" type="main">Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Cifuentes</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. Sci. USA</title>
		<meeting>. Natl Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="2004" />
			<biblScope unit="page" from="464" to="469" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b12">
	<analytic>
		<title level="a" type="main">Hierarchical structure and the prediction of missing links in networks</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Clauset</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">453</biblScope>
			<biblScope unit="page" from="98" to="101" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b13">
	<analytic>
		<title level="a" type="main">DAVID: database for annotation, visualization, and integrated discovery</title>
		<author>
			<persName>
				<forename type="first">G</forename>
				<surname>Dennis</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b14">
	<analytic>
		<title level="a" type="main">Gene-set analysis and reduction</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Dinu</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brief. Bioinform</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="24" to="34" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b15">
	<analytic>
		<title level="a" type="main">SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer</title>
		<author>
			<persName>
				<forename type="first">X</forename>
				<forename type="middle">Y</forename>
				<surname>Dong</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Mol. Genet</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1031" to="1042" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b16">
	<analytic>
		<title level="a" type="main">Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<forename type="middle">J</forename>
				<surname>Edelman</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="108" to="116" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b17">
	<analytic>
		<title level="a" type="main">Modeling cancer progression via pathway dependencies</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<forename type="middle">J</forename>
				<surname>Edelman</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Comput. Biol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">28</biblScope>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b18">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">095</biblScope>
			<biblScope unit="page" from="41" to="62" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note>btq207. .tex]</note>
</biblStruct>

<biblStruct   xml:id="b19">
	<monogr>
		<title/>
		<author>
			<persName>
				<surname>Page</surname>
			</persName>
		</author>
		<imprint>
			<biblScope unit="page" from="1512" to="1506" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b20">
	<monogr>
		<title/>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Park</surname>
			</persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b21">
	<analytic>
		<title level="a" type="main">Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer</title>
		<author>
			<persName>
				<surname>Eruslanov</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="page" from="7548" to="7557" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b22">
	<analytic>
		<title level="a" type="main">Molecular classification of cancer: class discovery and class prediction by gene expression monitoring</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<forename type="middle">R</forename>
				<surname>Golub</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="531" to="537" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b23">
	<analytic>
		<title level="a" type="main">Feature construction from synergic pairs to improve mi-croarray-based classification</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Hanczar</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="2866" to="2872" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b24">
	<analytic>
		<title level="a" type="main">Integrated analysis of breast cancer cell lines reveals unique signaling pathways</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<forename type="middle">M</forename>
				<surname>Heiser</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">31</biblScope>
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b25">
	<analytic>
		<title level="a" type="main">Prostate cancer risk and serum levels of insulin and leptin: a population-based study</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<forename type="middle">W</forename>
				<surname>Hsing</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Natl Cancer. Inst</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="783" to="789" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b26">
	<analytic>
		<title level="a" type="main">Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</title>
		<author>
			<persName>
				<forename type="first">W</forename>
				<surname>Huang Da</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b27">
	<analytic>
		<title level="a" type="main">Extensions to gene set enrichment</title>
		<author>
			<persName>
				<forename type="first">Z</forename>
				<surname>Jiang</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Gentleman</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="306" to="313" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b28">
	<analytic>
		<title level="a" type="main">Logic regression</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Ruczinski</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Comput. Graph. Stat</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="475" to="511" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b29">
	<analytic>
		<title level="a" type="main">Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target</title>
		<author>
			<persName>
				<forename type="first">P</forename>
				<forename type="middle">J</forename>
				<surname>Jakobsson</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. Sci. USA</title>
		<meeting>. Natl Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="1999" />
			<biblScope unit="page" from="7220" to="7225" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b30">
	<analytic>
		<title level="a" type="main">The KEGG resource for deciphering the genome</title>
		<author>
			<persName>
				<forename type="first">M</forename>
				<surname>Kanehisa</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="277" to="280" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b31">
	<analytic>
		<title level="a" type="main">Missing value estimation for DNA microarray gene expres-sion data: local least squares imputation</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<surname>Kim</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="187" to="198" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b32">
	<analytic>
		<title level="a" type="main">Gene expression profiling identifies clinically relevant subtypes of prostate cancer</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Lapointe</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. USA</title>
		<meeting>. Natl Acad. USA</meeting>
		<imprint>
			<date type="published" when="2004" />
			<biblScope unit="page" from="811" to="816" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b33">
	<analytic>
		<title level="a" type="main">Inferring pathway activity toward precise disease classification</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Lee</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Comput. Biol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b34">
	<analytic>
		<title level="a" type="main">TERT promotes cellular and organismal survival independently of telomerase activity</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Lee</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="3754" to="3760" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b35">
	<analytic>
		<title level="a" type="main">Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<forename type="middle">M</forename>
				<surname>Levine</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">93</biblScope>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b36">
	<analytic>
		<title level="a" type="main">Transforming growth factor-beta/SMAD3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<forename type="middle">M</forename>
				<surname>Lin</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="page" from="12246" to="12257" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b37">
	<analytic>
		<title level="a" type="main">Adenosine metabolism and cancer. Focus on &apos;Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Linden</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol. Cell. Physiol</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="405" to="406" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b38">
	<analytic>
		<title level="a" type="main">Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<forename type="middle">V</forename>
				<surname>Litvinov</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. Sci. USA</title>
		<meeting>. Natl Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="2006" />
			<biblScope unit="page" from="15085" to="15090" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b39">
	<analytic>
		<title level="a" type="main">PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<forename type="middle">K</forename>
				<surname>Mootha</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="267" to="273" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b40">
	<analytic>
		<title level="a" type="main">Immunohistochemical expression of pi-class gluta-thione S-transferase is down-regulated in adenocarcinoma of the prostate</title>
		<author>
			<persName>
				<forename type="first">C</forename>
				<forename type="middle">A</forename>
				<surname>Moskaluk</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="1595" to="1599" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b41">
	<analytic>
		<title level="a" type="main">Sparse combinatorial inference with an application in cancer biology</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<surname>Mukherjee</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="265" to="271" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b42">
	<analytic>
		<title level="a" type="main">Gene-set approach for expression pattern analysis</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Nam</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">Y</forename>
				<surname>Kim</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brief. Bioinform</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="189" to="197" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b43">
	<analytic>
		<title level="a" type="main">Mining gene expression profiles: expression signa-tures as cancer phenotypes</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<forename type="middle">R</forename>
				<surname>Nevins</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Potti</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Genet</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="601" to="609" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b44">
	<analytic>
		<title level="a" type="main">Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion, AMPK activation and induces senescence</title>
		<author>
			<persName>
				<forename type="first">O</forename>
				<surname>Obajimi</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prostate</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1206" to="1221" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b45">
	<analytic>
		<title level="a" type="main">DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Padmanabhan</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Pathol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1057" to="1062" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b46">
	<analytic>
		<title level="a" type="main">Pathway analysis using random forests classification and regression</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<surname>Pang</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="2028" to="2036" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b47">
	<analytic>
		<title level="a" type="main">Building pathway clusters from random forests classification using class votes</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<surname>Pang</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">H</forename>
				<surname>Zhao</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">87</biblScope>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b48">
	<analytic>
		<title level="a" type="main">Estimation of entropy and mutual information</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Paninski</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neural Comput</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1191" to="1253" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b49">
	<analytic>
		<title level="a" type="main">Diabetes mellitus and prostate cancer risk</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<forename type="middle">L</forename>
				<surname>Pierce</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prostate</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="1126" to="1132" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b50">
	<analytic>
		<title level="a" type="main">Identifying regulatory networks by combinatorial analysis of promoter elements</title>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<surname>Pilpel</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="153" to="159" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b51">
	<analytic>
		<title level="a" type="main">Genomic signatures to guide the use of chemotherapeutics</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Potti</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1294" to="1300" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b52">
	<analytic>
		<title level="a" type="main">A module map showing conditional activity of expression modules in cancer</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Segal</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1090" to="1098" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b53">
	<analytic>
		<title level="a" type="main">Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data</title>
		<author>
			<persName>
				<forename type="first">E</forename>
				<surname>Segal</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="166" to="176" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b54">
	<analytic>
		<title level="a" type="main">Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors</title>
		<author>
			<persName>
				<forename type="first">N</forename>
				<forename type="middle">L</forename>
				<surname>Sieben</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="7257" to="7264" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b55">
	<analytic>
		<title level="a" type="main">Gene expression correlates of clinical prostate cancer beha-vior</title>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Singh</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="203" to="209" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b56">
	<analytic>
		<title level="a" type="main">Repeated observation of breast tumor subtypes in independent gene expression data sets</title>
		<author>
			<persName>
				<forename type="first">T</forename>
				<surname>Sorlie</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. USA</title>
		<meeting>. Natl Acad. USA</meeting>
		<imprint>
			<date type="published" when="2003" />
			<biblScope unit="page" from="8418" to="8423" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b57">
	<analytic>
		<title level="a" type="main">Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Subramanian</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. Sci. USA</title>
		<meeting>. Natl Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="2005" />
			<biblScope unit="page" from="15545" to="15550" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b58">
	<analytic>
		<title level="a" type="main">Discovering statistically significant pathways in expression profiling studies</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<surname>Tian</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl Acad. Sci. USA</title>
		<meeting>. Natl Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="2005" />
			<biblScope unit="page" from="13544" to="13549" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b59">
	<analytic>
		<title level="a" type="main">Integrative molecular concept modeling of prostate cancer progression</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">A</forename>
				<surname>Tomlins</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="41" to="51" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b60">
	<analytic>
		<title level="a" type="main">Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer</title>
		<author>
			<persName>
				<forename type="first">H</forename>
				<forename type="middle">G</forename>
				<surname>Van Der Poel</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. Urol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1051" to="1058" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b61">
	<analytic>
		<title level="a" type="main">Gene expression profiling predicts clinical outcome of breast cancer</title>
		<author>
			<persName>
				<forename type="first">L</forename>
				<forename type="middle">J</forename>
				<surname>Van &apos;t Veer</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">415</biblScope>
			<biblScope unit="page" from="530" to="536" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b62">
	<analytic>
		<title level="a" type="main">Inference of disease-related molecular logic from systems-based microarray analysis</title>
		<author>
			<persName>
				<forename type="first">V</forename>
				<surname>Varadan</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">D</forename>
				<surname>Anastassiou</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Comput. Biol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">68</biblScope>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b63">
	<analytic>
		<title level="a" type="main">Reactome: a knowledge base of biologic pathways and processes</title>
		<author>
			<persName>
				<forename type="first">I</forename>
				<surname>Vastrik</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">39</biblScope>
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b64">
	<analytic>
		<title level="a" type="main">Identification of gene interactions associated with disease from gene expression data using synergy networks</title>
		<author>
			<persName>
				<forename type="first">J</forename>
				<surname>Watkinson</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Syst. Biol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">10</biblScope>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b65">
	<analytic>
		<title level="a" type="main">Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy</title>
		<author>
			<persName>
				<forename type="first">Y</forename>
				<forename type="middle">P</forename>
				<surname>Yu</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="2790" to="2799" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>